FindTrial
Sign In

To study the severity of bleeding during Transbronchial lung biopsy.

To study the incidence and severity of endobronchial bleeding during Transbronchial lung biopsy (TBLB) procedure in patients without known clinical risk factors for increased bleeding: A Prospective observational study. - BRIL Study (Bleeding Risk in Lung Biopsy)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/019147
Enrollment
436
Registered
2019-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J95- Intraoperative and postproceduralcomplications and disorders of respiratory system, not elsewhere classified

Interventions

None listed

Sponsors

Fluid Research Fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All male and female patients above the age of 18 years presenting to the department of Pulmonary Medicine department of CMC for Transbronchial Lung biopsy

Exclusion criteria

Exclusion criteria: -Known bleeding diathesis -Pregnant women -Thrombocytopenia -Chronic Kidney Disease -Chronic Liver Disease patients -Patients on Chemotherapy -Post Lung transplant -History of significant bleeding -post operative or trauma -History of severe epistaxis, GI bleed, hematuria, menorrhagia, petechiae, -Treatment with Anticoagulants -Patients in sepsis with shock or disseminated intravascular coagulation -Patients with low respiratory reserve -All patients who do not consent to the study

Design outcomes

Primary

MeasureTime frame
To study the incidence and severity of endobronchial bleeding during Transbronchial lung biopsy (TBLB) procedure.Timepoint: May 2019 to June 2020—

Secondary

MeasureTime frame
1.To assess the etiology of moderate to severe endobronchial bleeding in patients undergoing transbronchial biopsy procedure, in the department of pulmonary medicine. 2.To find the difference in proportion of patients with significant endobronchial bleeding during TBLB procedure performed for different lung pathologies. Timepoint: May 2019 to June 2020—

Countries

India

Contacts

Public ContactMATHEW VARGHESE NELLIMOOTIL

CHRISTIAN MEDICAL COLLEGE AND HOSPITAL

drprincej@gmail.com9600771709

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026